论文部分内容阅读
目的 :为了解白血病患者血浆纤维蛋白原 (FIB)、纤溶酶原 (PLG)和D -二聚体 (D -dimer)的活性变化。方法以STACompact全自动血凝仪及ACL - 2 0 0型自动血凝仪测定 2 0例正常健康人、 12例急性原始粒细胞白血病 (M1、M2 )、 10例急性早幼粒细胞白血病 (M3)、 8例急性淋巴细胞白血病 (ALL)、 6例慢性粒细胞白血病 (CML)患者血浆的纤维蛋白原含量 (FIB)、纤溶酶原活性 (PLG)及D -二聚体 (D -dimer)的量。结果 :正常对照组血浆FIB为 (2 70± 0 5 7)g/L、PLG活性为 (98 0± 11 0 ) %、D -dimer为 (0 2 8± 0 10 )mg/L ;M1与M2患者的FIB为 (2 76± 1 0 7)g/L、PLG活性为 (88 9± 11 6 ) %、D -dimer为 (1 41± 1 17)mg/L ;M3患者FIB为 (2 6 3± 1 2 4)g/L、PLG活性为 (85 1± 9 45 ) %、D -dimer为 (1 83± 1 36 )mg/L ;ALL患者的FIB为 (2 15± 1 2 2 )g/L、PLG活性为 (83 3± 9 2 1) %、D -dimer为 (2 33± 1 44 )mg/L ;CML患者的FIB为 (3 2 9± 0 80 )g/L、PLG活性为 (90 0± 12 1) %、D -dimer为 (0 47± 0 39)mg/L。与正常对照比较白血病患者血浆FIB含量无明显差异 (P >0 0 5 ) ,急性白血病患者血浆PLG活性降低 (P <0 0 5 )、D -dimer水平升高 (P <0 0 5 ) ;慢性白血病患者PLG和D -dimer
Objective: To investigate the changes of plasma fibrinogen (FIB), plasminogen (PLG) and D-dimer in patients with leukemia. Methods Twenty cases of normal healthy people, 12 cases of acute myeloid leukemia (M1, M2) and 10 cases of acute promyelocytic leukemia (M3) were detected by STACompact automated coagulation analyzer and ACL - 200 automatic coagulation analyzer. ), Plasma fibrinogen content (FIB), plasminogen activator (PLG) and D-dimer in 8 patients with acute lymphoblastic leukemia (ALL) and 6 patients with chronic myeloid leukemia (CML) ). Results: The FIB of normal control group was (2 70 ± 0 57) g / L, the activity of PLG was (98 0 ± 11 0)% and D-dimer was (0 28 ± 0 10) mg / M2 patients had FIB of (2 76 ± 1 0 7) g / L, PLG activity of (88 9 ± 11 6)% and D-dimer of (41 ± 1 17) mg / The mean PLG activity was (85 1 ± 9 45)% and D-dimer was (183 ± 1 36) mg / L, respectively. The FIB of ALL patients was (21 15 ± 1 2 4) g / ), the PLG activity was (83 3 ± 9 2 1)%, the D-dimer was (2 33 ± 1 44) mg / L; the FIB of CML patients was (3 2 9 ± 0 80) g / PLG activity was (90 0 ± 12 1)% and D-dimer was (0 47 ± 0 39) mg / L. There was no significant difference in plasma FIB levels between patients with leukemia and normal controls (P> 0.05), plasma PLG activity (P <0.05), D-dimer level (P <0.05) in patients with acute leukemia, chronic Leukemia PLG and D-dimer